Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol Acetate in AIDS Patients With Anorexia and Cachexia
NCT00002067Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in HIV wasting syndrome (HWS) and anorexia nervosa (AN) comparing Megestrol Acetate with Placebo (2 arms). Primary endpoints: Body weight, Anorexia and 3 more. Status: completed.
02
Drugs
megestrol
03
Conditions
HIV wasting syndrome (HWS)anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT00002067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002067.